RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Activated RAS promotes dimerization of members of the RAF kinase family1-3. ATP-competitive RAF inhibitors activate ERK signaling4-7 by transactivating RAF dimers4. In melanomas with mutant BRAF(V600E), levels of RAS activation are low and these drugs bind to BRAF(V600E) monomers and inhibit their a...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266695/ |